Ryan Abo
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 23
- Genetic Associations and Epidemiology 20
- Pharmacology 10
- Pharmacogenetics and Drug Metabolism 10
- Co-authors
- Stuart S. Levine (4 shared papers)Vincent L. Butty (2 shared papers)Steven R. Tannenbaum (3 shared papers)James A. Swenberg (3 shared papers)Katherine Ann Schlieper (3 shared papers)James G. Fox (3 shared papers)Kun Lü (3 shared papers)John S. Wishnok (3 shared papers)
- Journals
- Blood (3 papers)Pharmacogenetics and Genomics (3 papers)Proceedings of the National Academy of Sciences (3 papers)OMICS A Journal of Integrative Biology (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Ryan Abo
46 papers receiving 3.7k citations
Ryan Abo's Hit Papers
Peers
Comparison fields: 5 of 113
- Cancer Research 697
- Pathology and Forensic Medicine 344
- Oncology 407
- Environmental Chemistry 159
- Molecular Biology 1.1k
Countries citing papers authored by Ryan Abo
This map shows the geographic impact of Ryan Abo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Abo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Abo more than expected).
Fields of papers citing papers by Ryan Abo
This network shows the impact of papers produced by Ryan Abo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Abo. The network helps show where Ryan Abo may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryan Abo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment Hit paper breakdown → | 2013 | 785 |
| 2 | Targetable genetic features of primary testicular and primary central nervous system lymphomas Hit paper breakdown → | 2015 | 469 |
| 3 | 2014 | 455 | |
| 4 | 2016 | 390 | |
| 5 | 2014 | 154 | |
| 6 | 2021 | 129 | |
| 7 | 2014 | 125 | |
| 8 | 2014 | 121 | |
| 9 | 2014 | 97 | |
| 10 | 2011 | 93 | |
| 11 | 2013 | 77 | |
| 12 | 2016 | 77 | |
| 13 | 2014 | 64 | |
| 14 | 2013 | 57 | |
| 15 | 2021 | 56 | |
| 16 | 2012 | 51 | |
| 17 | 2010 | 45 | |
| 18 | 2019 | 41 | |
| 19 | 2013 | 40 | |
| 20 | 2012 | 37 |
About Ryan Abo
Ryan Abo is a scholar working on Genetics, Pharmacology, Molecular Biology, Rheumatology and Oncology, having authored 47 papers that have together received 3.7k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (20 papers), Pharmacogenetics and Drug Metabolism (10 papers), Folate and B Vitamins Research (4 papers), Lung Cancer Treatments and Mutations (3 papers), Bioinformatics and Genomic Networks (3 papers), Lymphoma Diagnosis and Treatment (3 papers), PARP inhibition in cancer therapy (3 papers) and Legume Nitrogen Fixing Symbiosis (2 papers). The work is most often cited by research in Cancer Research (697 citations), Pathology and Forensic Medicine (344 citations), Oncology (407 citations), Environmental Chemistry (159 citations) and Molecular Biology (1.1k citations). Ryan Abo has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Stuart S. Levine, Vincent L. Butty, Steven R. Tannenbaum, James A. Swenberg, Katherine Ann Schlieper, James G. Fox, Kun Lü, John S. Wishnok, Matthew L. Steinhauser and Laurie A. Boyer. Their work appears in journals such as Blood, Pharmacogenetics and Genomics, Proceedings of the National Academy of Sciences, OMICS A Journal of Integrative Biology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.